Ajay Kumar/LinkedIn
Mar 2, 2026, 16:09
Ajay Kumar: The Progression of HDFN – From Fetal Anemia to Kernicterus
Ajay Kumar, Senior Resident at Geetanjali Hospital, shared a post on LinkedIn:
“As a transfusion medicine specialist, I often emphasize the importance of early Antibody Screening in pregnancy.
Haemolytic Disease of the Fetus and Newborn (HDFN) is a preventable yet potentially life-threatening condition.
Timely antenatal antibody screening, appropriate monitoring, and interventions like intrauterine transfusion (IUT) or phototherapy can save lives and prevent permanent neurological damage.
Prevention and vigilance remain our strongest tools.”
Stay updated with Hemostasis Today.
-
Sep 5, 2026, 10:23Danny Hsu: Honouring Rob Bird’s Career and Impact in Haematology
-
Sep 5, 2026, 10:12Wolfgang Miesbach: Can Emicizumab Be Used During Breastfeeding?
-
Sep 5, 2026, 09:52Lorena Arranz: Shaping the Future of Hematology with EHA 2027
-
Sep 5, 2026, 07:35Anticoagulation and Contemporary Secondary Prevention of Thrombosis in Polycythemia Vera
-
Sep 5, 2026, 05:48Punit Mathur: From Leg Pain to Life-Threatening Pulmonary Embolism
-
Sep 5, 2026, 05:44Patrick Stonich: Identifying Missed Signs of Postoperative Pulmonary Embolism in Medical Record Reviews
-
Sep 5, 2026, 05:38Tom Van den Hoek: Warburg Effect Mimicking Refractory Shock in Cancer-Associated PE
-
Sep 5, 2026, 05:11Shinya Goto: Targeted Thrombolysis for High Risk Pulmonary Embolism
-
Sep 5, 2026, 04:56Opportunities for the Next Generation of Hematologists – American Society of Hematology